Evidence map›Paper›PMID 36149470›Full record

ArticleArchives of toxicology2023

Practical application of the interim internal threshold of toxicological concern (iTTC): a case study based on clinical data.

Abdulkarim Najjar, Corie A Ellison, Sebastien Gregoire, Nicola J Hewitt

Erratum issuedAbstract read
In one paragraph

Article in Archives of toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Abdulkarim Najjar *Beiersdorf AG, Unnastrasse 48, 20245, Hamburg, Germany.ORCID 0000-0003-4620-9830
Corie A Ellison *The Procter & Gamble Company, 8700 Mason Montgomery Road, Cincinnati, OH, 45040, USA. Ellison.ca@pg.com.ORCID 0000-0002-1069-5139
Sebastien GregoireL'Oreal Research & Innovation, 1, Avenue Eugène Schueller, 93601, Aulnay-sous-Bois, France.ORCID 0000-0003-3474-6129
Nicola J HewittCosmetics Europe, Avenue Herrmann-Debroux 40, 1160, Brussels, Belgium.ORCID 0000-0002-1045-0748

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a case study that provides a practical step-by-step example of how the internal Threshold of Toxicological Concern (iTTC) can be used as a tool to refine a TTC-based assessment for dermal exposures to consumer products. The case study uses a theoretical scenario where there are no systemic toxicity data for the case study chemicals (avobenzone, oxybenzone, octocrylene, homosalate, octisalate, octinoxate, and ecamsule). Human dermal pharmacokinetic data following single and repeat dermal exposure to products containing the case study chemicals were obtained from data published by the US FDA. The clinical studies utilized an application procedure that followed maximal use conditions (product applied as 2 mg/cm

Indexed as

BenzophenonesHumansRisk AssessmentBenzophenonesoxybenzoneCosmetics ingredientsDecision treeDermal exposureiTTCPBPKRisk assessmentSystemic toxicityUV filter

Identifiers

PMID36149470
PMCPMC9816204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.